Table 6 |
|||
The impact of return treatment on time required for gonorrhoea and chlamydia to be eliminated and on chlamydia prevalence | |||
Return treatment probability (%) | Number of eliminations (out of 100 runs) | Years required for elimination of gonorrhoea | |
Median | 25th-75th percentile | ||
0 | 94 | 25.0 | 17.0-36.9 |
5 | 100 | 10.3 | 7.8-13.0 |
10 | 100 | 10.3 | 7.9-14.0 |
Return treatment probability (%) | Number of eliminations (out of 100 runs) | Chlamydia prevalence at the end of 60 years (%) | |
Median | 25th-75th percentile | ||
0 | 0 | 7.0 | 6.0-8.7 |
5 | 2 | 3.5 | 2.1-4.6 |
10 | 27 | 1.0 | 0-2.2 |
For all simulation runs in the figure, residents with symptoms will be treated at a rate such that 25% of infected individuals receive treatment in 25 days (i.e. at a rate of 0.011 per day). Under return treatment, all symptomatic and a proportion (5% and 10%) of asymptomatic infected non-residents are treated upon return to their home location.
Hui et al.
Hui et al. BMC Infectious Diseases 2013 13:188 doi:10.1186/1471-2334-13-188